• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.03% Nasdaq Up 1.29%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    172.50 Up 3.27(1.93%) May 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:169.23
    Open:170.66
    Bid:168.81 x 100
    Ask:N/A
    1y Target Est:214.52
    Beta:1.19
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:170.42 - 175.00
    52wk Range:147.81 - 203.30
    Volume:955,162
    Avg Vol (3m):1,245,470
    Market Cap:34.44B
    P/E (ttm):52.91
    EPS (ttm):3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 1.93%34.44B
    AMGNUp 1.55%121.87B
    BAXUp 1.00%37.74B

    Key Statistics

    Forward P/E (1 yr):23.70
    P/S (ttm):15.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.87
    Quarterly EPS Est (Jun-15) :1.41
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback